Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Angina Pectoris D000787 27 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Jores K et al. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. 2005 Pharm. Res. pmid:16132349
Videira MA et al. Lymphatic uptake of lipid nanoparticles following endotracheal administration. 2006 J Microencapsul pmid:17390627
Pedersen N et al. Solid lipid nanoparticles can effectively bind DNA, streptavidin and biotinylated ligands. 2006 Eur J Pharm Biopharm pmid:16290122
Souto EB et al. Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC. 2006 J Microencapsul pmid:16854817
Hamdani J et al. Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. 2006 Int J Pharm pmid:16824707
Li FQ et al. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. 2006 Int J Pharm pmid:16837152
Hamdani J et al. In vitro and in vivo evaluation of floating riboflavin pellets developed using the melt pelletization process. 2006 Int J Pharm pmid:16815656
Furlanetto S et al. Study of formulation variables influencing the drug release rate from matrix tablets by experimental design. 2006 Eur J Pharm Biopharm pmid:16154333
Castro GA et al. Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. 2007 J Microencapsul pmid:17578730
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840